As the year-end is drawing nearby, it’s time to retrospect on all the Regulatory actions that the Pharma industry stood by to fall in compliance with Health Authority mandates. It is worthwhile to reflect upon the influential industry trends, HA guidance documents and major industry challenges that we’ve been covering in the last 12 months. Highlighting the major breakthroughs, here we give you a relook at top 20 topics we’ve covered in 2016 including submission and labeling mandates, the Brexit and the aftermath, mandates and amendments, and some of the opinions.
We hope this relook will help you reexamine the Regulatory actions in the past year and realign with that of the upcoming one. Wishing you a great holiday season ahead, we thank you for reading!